COMT — Catechol-O-Methyltransferase
Chromosome 22q11.21
Degrades catecholamines (dopamine, epinephrine, norepinephrine) in the prefrontal cortex. The Val/Met polymorphism creates a spectrum of dopamine metabolism rates affecting cognition, pain, and stress response.
Pharmacogenomic Variants
Peptide Therapeutic Approaches
COMT-stabilizing peptides for the Met allele, allosteric modulators for activity normalization, and genotype-informed analgesic peptide design.
Related Therapeutics
Entacapone (COMT inhibitor)Morphine (affected by COMT status)
Associated Conditions
Analyze COMT variants with PepFold
Submit rs4680 and get ranked peptide candidates in under 2 minutes.